Vor Biopharma Inc. Shares Outstanding (Cover Page)
Vor Biopharma Inc. (VOR) had Shares Outstanding (Cover Page) of 59.16 million shares as of 2026-08-06, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-06: Entity Common Stock, Shares Outstanding 59.16M shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 54.19M shares.
- 2026-03-23: Entity Common Stock, Shares Outstanding 48.85M shares.
- 2025-11-07: Entity Common Stock, Shares Outstanding 10.41M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 59.16M shares 10-Q · filed 2026-08-11 |
| 2026-05-07 | 54.19M shares 10-Q · filed 2026-05-13 |
| 2026-03-23 | 48.85M shares 10-K · filed 2026-03-30 |
| 2025-11-07 | 10.41M shares 10-Q · filed 2025-11-13 |
| 2025-08-06 | 126.68M shares 10-Q · filed 2025-08-12 |
| 2025-05-08 | 124.96M shares 10-Q · filed 2025-05-14 |
| 2025-03-13 | 124.85M shares 10-K · filed 2025-03-20 |
| 2024-11-01 | 68.67M shares 10-Q · filed 2024-11-07 |
| 2024-08-02 | 68.40M shares 10-Q · filed 2024-08-08 |
| 2024-05-09 | 68.26M shares 10-Q · filed 2024-05-09 |
| 2024-05-03 | 68.26M shares 10-Q/A · filed 2024-08-08 |
| 2024-03-15 | 68.17M shares 10-K · filed 2024-03-20 |
| 2023-11-07 | 67.81M shares 10-Q · filed 2023-11-07 |
| 2023-08-10 | 67.54M shares 10-Q · filed 2023-08-10 |
| 2023-05-05 | 66.96M shares 10-Q · filed 2023-05-11 |
| 2023-03-17 | 66.37M shares 10-K · filed 2023-03-23 |
| 2022-11-04 | 38.67M shares 10-Q · filed 2022-11-10 |
| 2022-08-05 | 38.06M shares 10-Q · filed 2022-08-11 |
| 2022-05-06 | 37.60M shares 10-Q · filed 2022-05-12 |
| 2022-03-04 | 37.49M shares 10-K · filed 2022-03-14 |
| 2021-11-05 | 37.29M shares 10-Q · filed 2021-11-10 |
| 2021-08-02 | 37.14M shares 10-Q · filed 2021-08-09 |
| 2021-04-30 | 37.13M shares 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |